ContraFect (CFRX) Announces ANSM Approval of Clinical Trial

ContraFect (CFRX) Announces ANSM Approval of Clinical Trial Application for Exebacase in Prosthetic Joint Infections

ContraFect (CFRX) Announces ANSM Approval of Clinical Trial Application for Exebacase in Prosthetic Joint Infections
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Related Keywords

France , French , Rogerj Pomerantz , , Contrafect Corporation Nasdaq , Health Products , Wall Street , Fect Corporation , French National Agency , Clinical Trial Application , Coagulase Negative Staphylococci , Chief Executive Officer ,